NCT07039110 Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis Status RECRUITING Phase N/A
NCT07038720 A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis Status RECRUITING Phase PHASE1
NCT07024602 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis Status RECRUITING Phase PHASE1
NCT07008547 To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT07001904 Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity Status COMPLETED Phase N/A
NCT06997055 ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar Status RECRUITING Phase N/A
NCT06979453 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis Status RECRUITING Phase PHASE3
NCT06973291 A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT06972888 A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT06945107 A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06934226 A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06846541 Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06808815 A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT06802848 Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) Status NOT_YET_RECRUITING Phase N/A
NCT06790940 Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information Status NOT_YET_RECRUITING Phase N/A
NCT06723171 Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis Status SUSPENDED Phase PHASE2
NCT06648772 Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study Status RECRUITING Phase PHASE3
NCT06643260 A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy Status NOT_YET_RECRUITING Phase PHASE3
NCT06640517 Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06630559 A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3